Share Immunisation Community of Practice on FacebookShare Immunisation Community of Practice on TwitterShare Immunisation Community of Practice on LinkedinEmail Immunisation Community of Practice link
Welcome to the Immunisation Community of Practice. A community of practice (CoP) is a group of people with a shared passion who come together and learn how to do better. The PHNs Immunisation CoP is your opportunity to get answers, share ideas and build your professional network regarding immunisation.
The PHN Immunisation CoP aims to reduce the incidence of vaccine preventable diseases in the community by providing appropriate and timely information about vaccine preventable diseases and the Immunise Australia Program to immunisation providers and the community and promote the delivery of the National Immunisation Program (NIP).
Immunisation is a simple, safe and effective way of protecting people against harmful diseases that can cause serious health problems in the community. Immunisation not only protects individuals from life-threatening diseases, but also dramatically reduces transmission in the community. The more people who are vaccinated, the fewer opportunities a disease has to spread.
Some of the benefits of joining this Community are:
24/7 access to filed Immunisation resources,
keep current with Immunisation updates,
brainstorm about Immunisation,
and network with colleagues passionate about Immunisation.
Welcome to the Immunisation Community of Practice. A community of practice (CoP) is a group of people with a shared passion who come together and learn how to do better. The PHNs Immunisation CoP is your opportunity to get answers, share ideas and build your professional network regarding immunisation.
The PHN Immunisation CoP aims to reduce the incidence of vaccine preventable diseases in the community by providing appropriate and timely information about vaccine preventable diseases and the Immunise Australia Program to immunisation providers and the community and promote the delivery of the National Immunisation Program (NIP).
Immunisation is a simple, safe and effective way of protecting people against harmful diseases that can cause serious health problems in the community. Immunisation not only protects individuals from life-threatening diseases, but also dramatically reduces transmission in the community. The more people who are vaccinated, the fewer opportunities a disease has to spread.
Some of the benefits of joining this Community are:
24/7 access to filed Immunisation resources,
keep current with Immunisation updates,
brainstorm about Immunisation,
and network with colleagues passionate about Immunisation.
Share Update to the Australian Immunisation Handbook on FacebookShare Update to the Australian Immunisation Handbook on TwitterShare Update to the Australian Immunisation Handbook on LinkedinEmail Update to the Australian Immunisation Handbook link
The Australian Immunisation Handbook has recently updated a number of pages and the updates can be viewed on the Handbook website.
The Australian Immunisation Handbook has recently updated a number of pages and the updates can be viewed on the Handbook website.
Share AIR 42A Report update Dec 2022 on FacebookShare AIR 42A Report update Dec 2022 on TwitterShare AIR 42A Report update Dec 2022 on LinkedinEmail AIR 42A Report update Dec 2022 link
From 3 December 2022 the AIR042A report will be temporarily unavailable whilst enhancements are made to improve usability and to future proof the report so that it is aligned with evolving clinical advice regarding multiple boosters and new COVID-19 vaccines. Vaccination providers will still be able to access and view reports that they’ve requested prior to 3 December 2022.
It is anticipated the enhanced AIR042A report will be available for vaccination providers to use from March 2023.
From 3 December 2022 the AIR042A report will be temporarily unavailable whilst enhancements are made to improve usability and to future proof the report so that it is aligned with evolving clinical advice regarding multiple boosters and new COVID-19 vaccines. Vaccination providers will still be able to access and view reports that they’ve requested prior to 3 December 2022.
It is anticipated the enhanced AIR042A report will be available for vaccination providers to use from March 2023.
Share Expansion of the NSW pharmacist vaccination program on FacebookShare Expansion of the NSW pharmacist vaccination program on TwitterShare Expansion of the NSW pharmacist vaccination program on LinkedinEmail Expansion of the NSW pharmacist vaccination program link
The NSW pharmacist vaccination program has been expanded to include 6 additional vaccines:
Hepatitis A
Hepatitis B
Japanese encephalitis – completion of an additional education module is mandatory
Share Discontinued: Moderna Original COVID-19 vaccine on FacebookShare Discontinued: Moderna Original COVID-19 vaccine on TwitterShare Discontinued: Moderna Original COVID-19 vaccine on LinkedinEmail Discontinued: Moderna Original COVID-19 vaccine link
All sites will have their allocation for Moderna ancestral (red cap) set to zero in COVID-19 Vaccine Administrative System (CVAS) from Saturday 22 October 2022. Sites were able to place their last order for Moderna ancestral by midnight Friday 21 October 2022.
All sites will have their allocation for Moderna ancestral (red cap) set to zero in COVID-19 Vaccine Administrative System (CVAS) from Saturday 22 October 2022. Sites were able to place their last order for Moderna ancestral by midnight Friday 21 October 2022.
Share Caution: COVID-19 vaccine dosing & administration errors on FacebookShare Caution: COVID-19 vaccine dosing & administration errors on TwitterShare Caution: COVID-19 vaccine dosing & administration errors on LinkedinEmail Caution: COVID-19 vaccine dosing & administration errors link
Immunisation providers are advised to exercise caution especially when administering Moderna vaccines to avoid potential dosing errors and incorrect vaccine selection. Several vaccine administration errors (VAEs) have been reported since the roll-out of the Moderna Bivalent 18 years+ (Blue/Green) vaccine.
The correct dosage of Moderna Bivalent 18 years + vaccine is 0.50mL (rather than 0.25mL). The vaccine comes in 2.5mL vials, with 5 doses contained within each vial. Providers are strongly advised to use the COVID vaccine comparison poster to check dose and brand suitability.
Immunisation providers are advised to exercise caution especially when administering Moderna vaccines to avoid potential dosing errors and incorrect vaccine selection. Several vaccine administration errors (VAEs) have been reported since the roll-out of the Moderna Bivalent 18 years+ (Blue/Green) vaccine.
The correct dosage of Moderna Bivalent 18 years + vaccine is 0.50mL (rather than 0.25mL). The vaccine comes in 2.5mL vials, with 5 doses contained within each vial. Providers are strongly advised to use the COVID vaccine comparison poster to check dose and brand suitability.
Share Update to AIR vaccination provider form on FacebookShare Update to AIR vaccination provider form on TwitterShare Update to AIR vaccination provider form on LinkedinEmail Update to AIR vaccination provider form link
Two new provider types, Residential Care Facilities (RCFs) and Authorised Nurses Immunisers (ANIs) have been added to the Australian Immunisation Register (AIR) and can apply for an AIR Provider Number. This AIR update provides information and advice on possible scenarios.
The advice is that a nurse in general practice is not required to get an AIR provider number and therefore an ABN is not needed.
If someone is working as a contractor and needs an ABN they can apply directly to the ABR and there is no fee to get an ABN.
Q In what settings should an ANI apply for an AIR provider number?
A In NSW a Registered Nurse/Midwife who holds the relevant qualifications for administering immunisations independently, has an ABN and who:
plans on administering vaccines independently, or
administers vaccines at a location that does not already have or is unable to register for an AIR provider number
Two new provider types, Residential Care Facilities (RCFs) and Authorised Nurses Immunisers (ANIs) have been added to the Australian Immunisation Register (AIR) and can apply for an AIR Provider Number. This AIR update provides information and advice on possible scenarios.
The advice is that a nurse in general practice is not required to get an AIR provider number and therefore an ABN is not needed.
If someone is working as a contractor and needs an ABN they can apply directly to the ABR and there is no fee to get an ABN.
Q In what settings should an ANI apply for an AIR provider number?
A In NSW a Registered Nurse/Midwife who holds the relevant qualifications for administering immunisations independently, has an ABN and who:
plans on administering vaccines independently, or
administers vaccines at a location that does not already have or is unable to register for an AIR provider number
Share Amended Authority for Nurse/Midwife Immunisers and learning resource on FacebookShare Amended Authority for Nurse/Midwife Immunisers and learning resource on TwitterShare Amended Authority for Nurse/Midwife Immunisers and learning resource on LinkedinEmail Amended Authority for Nurse/Midwife Immunisers and learning resource link
The Authority for Nurse/Midwife Immunisers has been amended to include the following additional vaccines:
Japanese encephalitis vaccines – mandatory training required
Typhoid vaccines
Herpes Zoster – Shingrix only. Does not include Zostavax
Share Help shape the future of vaccine safety surveillance in Australia – GPs, practice nurses and pharmacists needed on FacebookShare Help shape the future of vaccine safety surveillance in Australia – GPs, practice nurses and pharmacists needed on TwitterShare Help shape the future of vaccine safety surveillance in Australia – GPs, practice nurses and pharmacists needed on LinkedinEmail Help shape the future of vaccine safety surveillance in Australia – GPs, practice nurses and pharmacists needed link
Researchers at the National Centre for Immunisation Research and Surveillance (NCIRS) are conducting a study investigating the current utilisation of vaccine safety surveillance systems by immunisation providers across Australia. To help inform this study, you are invited to participate in a short telephone or videoconference interview to share your experiences – good, bad or non-existent – with vaccine safety surveillance systems in your daily practice.
The findings from this study will help improve vaccine safety surveillance systems in Australia, ensuring they are fit-for-purpose for the needs of you and your patients in the future.
Participants will be given a voucher for their time and interviews can be scheduled at a time that suits you to ensure there is no impact on your ability to see patients. Interviews will take place throughout October and November.
For further information or if you have any questions about the study, please email NCIRS Senior Program Officer, Nicola Carter at Nicola.Carter@health.nsw.gov.au
Expressions of interest close 30 October 2022.
Researchers at the National Centre for Immunisation Research and Surveillance (NCIRS) are conducting a study investigating the current utilisation of vaccine safety surveillance systems by immunisation providers across Australia. To help inform this study, you are invited to participate in a short telephone or videoconference interview to share your experiences – good, bad or non-existent – with vaccine safety surveillance systems in your daily practice.
The findings from this study will help improve vaccine safety surveillance systems in Australia, ensuring they are fit-for-purpose for the needs of you and your patients in the future.
Participants will be given a voucher for their time and interviews can be scheduled at a time that suits you to ensure there is no impact on your ability to see patients. Interviews will take place throughout October and November.
For further information or if you have any questions about the study, please email NCIRS Senior Program Officer, Nicola Carter at Nicola.Carter@health.nsw.gov.au
Share Flu reimbursement - vendor invite not received?? on FacebookShare Flu reimbursement - vendor invite not received?? on TwitterShare Flu reimbursement - vendor invite not received?? on LinkedinEmail Flu reimbursement - vendor invite not received?? link
If your practice has not received the vendor email invite to obtain your reimbursement for private flu vaccines. Please email kwisemantel@thephn.com.au with your details and best email address and I can action it with the Ministry of Health.
If your practice has not received the vendor email invite to obtain your reimbursement for private flu vaccines. Please email kwisemantel@thephn.com.au with your details and best email address and I can action it with the Ministry of Health.
Share ATAGI clinical guidance on COVID-19 vaccine administration errors (updated 7 September 2022) on FacebookShare ATAGI clinical guidance on COVID-19 vaccine administration errors (updated 7 September 2022) on TwitterShare ATAGI clinical guidance on COVID-19 vaccine administration errors (updated 7 September 2022) on LinkedinEmail ATAGI clinical guidance on COVID-19 vaccine administration errors (updated 7 September 2022) link
The Australian Technical Advisory Group on Immunisation (ATAGI) has developed guidelines to provide advice on the management of a range of possible vaccine administration errors, including when a replacement (repeat) dose is recommended. The guidelines are available on the Department of Health and Aged Care website.
The latest version (7 September 2022) includes updated advice on incorrect storage and handling and consolidated advice on unapproved age group.
The Australian Technical Advisory Group on Immunisation (ATAGI) has developed guidelines to provide advice on the management of a range of possible vaccine administration errors, including when a replacement (repeat) dose is recommended. The guidelines are available on the Department of Health and Aged Care website.
The latest version (7 September 2022) includes updated advice on incorrect storage and handling and consolidated advice on unapproved age group.
